<div><p>The hallmarks of many haematological malignancies and solid tumours are chromosomal translocations, which may lead to gene fusions. Recently, next-generation sequencing techniques at the transcriptome level (RNA-Seq) have been used to verify known and discover novel transcribed gene fusions. We present FusionFinder, a Perl-based software designed to automate the discovery of candidate gene fusion partners from single-end (SE) or paired-end (PE) RNA-Seq read data. FusionFinder was applied to data from a previously published analysis of the K562 chronic myeloid leukaemia (CML) cell line. Using FusionFinder we successfully replicated the findings of this study and detected additional previously unreported fusion genes in their dataset,...
none11Motivation: Next-generation sequencing technology allows the detection of genomic structural v...
Fusion genes are known to be key drivers of tumor growth in several types of cancer. Traditionally, ...
Background Fusion genes are known to be drivers of many common cancers, so they are...
The hallmarks of many haematological malignancies and solid tumours are chromosomal translocations, ...
The hallmarks of many haematological malignancies and solid tumours are chromosomal translocations, ...
Abstract Background In cancer, genomic rearrangements can create fusion genes that either combine pr...
Background: Gene fusions, which result from abnormal chromosome rearrangements, are a pathogenic fac...
Background: Genomic profiling efforts have revealed a rich diversity of oncogenic fusion genes. Whil...
Recurrent oncogenic fusion genes play a critical role in the development of various cancers and dise...
Motivation Fusion genes created by genomic rearrangements can be potent drivers of tumorigenesis. Ho...
BackgroundUntil recently, chromosomal translocations and fusion genes have been an underappreciated ...
Background We have evaluated an NGS-based method to detect recurrent gene fusions of diagnostic and ...
Nowadays there exist many bioinformatics tools that analyse sequencing data to identify genetic aber...
Gene fusions are common driver events in leukae-mias and solid tumours; here we present FusionAnalys...
Abstract Background Genomic rearrangements in cancer cells can create fusion genes that encode chime...
none11Motivation: Next-generation sequencing technology allows the detection of genomic structural v...
Fusion genes are known to be key drivers of tumor growth in several types of cancer. Traditionally, ...
Background Fusion genes are known to be drivers of many common cancers, so they are...
The hallmarks of many haematological malignancies and solid tumours are chromosomal translocations, ...
The hallmarks of many haematological malignancies and solid tumours are chromosomal translocations, ...
Abstract Background In cancer, genomic rearrangements can create fusion genes that either combine pr...
Background: Gene fusions, which result from abnormal chromosome rearrangements, are a pathogenic fac...
Background: Genomic profiling efforts have revealed a rich diversity of oncogenic fusion genes. Whil...
Recurrent oncogenic fusion genes play a critical role in the development of various cancers and dise...
Motivation Fusion genes created by genomic rearrangements can be potent drivers of tumorigenesis. Ho...
BackgroundUntil recently, chromosomal translocations and fusion genes have been an underappreciated ...
Background We have evaluated an NGS-based method to detect recurrent gene fusions of diagnostic and ...
Nowadays there exist many bioinformatics tools that analyse sequencing data to identify genetic aber...
Gene fusions are common driver events in leukae-mias and solid tumours; here we present FusionAnalys...
Abstract Background Genomic rearrangements in cancer cells can create fusion genes that encode chime...
none11Motivation: Next-generation sequencing technology allows the detection of genomic structural v...
Fusion genes are known to be key drivers of tumor growth in several types of cancer. Traditionally, ...
Background Fusion genes are known to be drivers of many common cancers, so they are...